Spectrum of effects as shown in clinical studies
Effects of etomoxir in type 2 diabetics in comparison with placebo. Maximal effects as means. Various studies with 200 patients.
| Fasting blood glucose | - 18% | |
| Keton bodies | - 78% | |
| Triglycerides | - 54% | |
| Total cholesterol | - 28% | |
| LDL-Cholesterol | - 44% | |
| HDL-Cholesterol | + 39% | |
| Metabolic Clearance Rate | + 33% | |
Effects of etomoxir in heart insufficient patients (NYHA II – III). Maximal effects as means. Two studies with 110 patients.
| Max. cardiac output | + 33% | |
| Max. stroke volume | + 31% | |
| Left ventricular Ejection fraction | + 22% | |
| Triglycerides | - 31% | |
| Total cholesterol | - 9% | |
| LDL-Cholesterol | + 13% | |
| HDL-Cholesterol | + 63% | |